cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc233ymt
title: CCDC 1940216: Experimental Crystal Structure Determination

description: Related Article: Chengwei Liu, Roger Lalancette, Roman Szostak, Michal Szostak|2019|Org.Lett.|21|7976|doi:10.1021/acs.orglett.9b02961
DOI: 10.5517/ccdc.csd.cc23m40x
title: CCDC 1954798: Experimental Crystal Structure Determination

description: Related Article: Arnold L. Rheingold and Richard L. Wells|2019|CSD Communication|||
DOI: 10.25318/3210007401-eng
title: Distribution of farm operators by income group and farm type, with selected average incomes

description: Distribution of farm operators by income group and farm type, with selected average incomes, unincorporated sector (in dollars), for Canada. Data are available on an annual basis.
DOI: 10.25318/3210007401-fra
title: Répartition des exploitants agricoles selon la tranche de revenu et le type d'exploitation agricole, y compris certains revenus moyens

description: Répartition des exploitants agricoles selon la tranche de revenu et le type d'exploitation agricole, y compris certains revenus moyens, secteur non constitué en société (en dollars), pour le Canada. Les données sont disponibles sur une base annuelle.
DOI: 10.25318/3210007501-eng
title: Average total income of farm operators by income quintile

description: Average total income of farm operators by income quintile, unincorporated sector (in dollars), for Canada and the provinces. Data are available on an annual basis.
DOI: 10.25318/3210007501-fra
title: Revenu total moyen des exploitants agricoles selon le quintile de revenu

description: Revenu total moyen des exploitants agricoles selon le quintile de revenu, secteur non constitué en société (en dollars), pour le Canada et les provinces. Les données sont disponibles sur une base annuelle.
DOI: 10.25318/3210007601-eng
title: Average total income of farm operators by income quintile and farm type

description: Average total income of farm operators by income quintile and farm type, unincorporated sector (in dollars), for Canada. Data are available on an annual basis.
DOI: 10.25318/3210007601-fra
title: Revenu total moyen des exploitants agricoles selon le quintile de revenu et le type d'exploitation agricole

description: Revenu total moyen des exploitants agricoles selon le quintile de revenu et le type d'exploitation agricole, secteur non constitué en société (en dollars), pour le Canada. Les données sont disponibles sur une base annuelle.
DOI: 10.25592/dgs.corpus-type-76381
title: KINDERZIMMER-$KANDIDAT-LEI51^ (MEINE DGS – annotiert. Öffentliches Korpus der Deutschen Gebärdensprache, mehrere Releases)
title: CHILDRENS-ROOM-$CANDIDATE-LEI51^ (MY DGS – annotated. Public Corpus of German Sign Language, several releases)

description: Ein Type aus der Annotation von MEINEDGS mit allen seinen Tokens aus MEINEDGS: The Public DGS Corpus consists of more than 50 hours of video data from the DGS-Korpus project made available together with annotations for research purposes. In this project, data were collected all across Germany in the timeframe 2010-2012. The public corpus shows 330 informants in 4 different age groups (from 18 years on) from 13 different regions. All parts are conversations between two informants in German Sign Language (DGS). The majority of transcripts included cover discussions and reports on Deaf life and personal experiences, although there are examples of other tasks such as story retellings as well.<br>Transcripts are made available in iLex and ELAN format as well as in SRT subtitles format that can be imported in MaxQDA and other analysis tools, together with the mp4 video files in 360p50. Über diese versionsunabhängige DOI ist die jeweils neueste Version des Datensatzes auffindbar.
description: A type from the annotation of MYDGS including all its tokens in MYDGS: Das Öffentliche DGS-Korpus besteht aus mehr als 50 Stunden Video aus dem Projekt DGS-Korpus , die zusammen mit Annotationen für Forschungszwecke zur Verfügung gestellt werden. Die Datenerhebung im Projekt fand im Zeitraum 2010-2012 in ganz Deutschland statt. Das öffentliche Korpus besteht aus Gesprächen jeweils zweier Informantinnen oder Informanten in Deutscher Gebärdensprache. Das Korpus umfasst 330 Informantinnen und Informanten in vier verschiedenen Altersgruppen (ab 18 Jahren) aus 13 verschiedenen Regionen. Der Schwerpunkt der Sammlung liegt auf Transkripten von Diskussionen und Berichten über das Leben Gehörloser sowie persönliche Erfahrungen, sie enthält aber auch Beispiele anderer Erhebungsformate wie Nacherzählungen.<br>Transkripte werden im iLex- und ELAN-Format sowie als SRT-Untertiteldateien (zum Import etwa in MaxQDA) zur Verfügung gestellt. Die zugehörigen MP4-Videodaten sind durchgängig im Format 360p50. This version-dependent DOI allows you to find the latest version of the dataset.
DOI: 10.5517/ccdc.csd.cc1nh78n
title: CCDC 1533981: Experimental Crystal Structure Determination

description: Related Article: Ilir Pecnikaj,  Francesca Foschi,  Raffaella Bucci,  Maria Luisa Gelmi,  Carlo Castellano,  Fiorella Meneghetti,  Michele Penso|2019|Eur.J.Org.Chem.|2019|6707|doi:10.1002/ejoc.201901325
DOI: 10.5517/ccdc.csd.cc1nh7bq
title: CCDC 1533983: Experimental Crystal Structure Determination

description: Related Article: Ilir Pecnikaj,  Francesca Foschi,  Raffaella Bucci,  Maria Luisa Gelmi,  Carlo Castellano,  Fiorella Meneghetti,  Michele Penso|2019|Eur.J.Org.Chem.|2019|6707|doi:10.1002/ejoc.201901325
DOI: 10.5517/ccdc.csd.cc22gmv1
title: CCDC 1920693: Experimental Crystal Structure Determination

description: Related Article: K. Mencel, P. Starynowicz, M. Siczek, A. Piecha-Bisiorek, R. Jakubas, W. Medycki|2019|Dalton Trans.|48|14829|doi:10.1039/C9DT02916H
DOI: 10.5517/ccdc.csd.cc22gmw2
title: CCDC 1920694: Experimental Crystal Structure Determination

description: Related Article: K. Mencel, P. Starynowicz, M. Siczek, A. Piecha-Bisiorek, R. Jakubas, W. Medycki|2019|Dalton Trans.|48|14829|doi:10.1039/C9DT02916H
DOI: 10.5517/ccdc.csd.cc22gmx3
title: CCDC 1920695: Experimental Crystal Structure Determination

description: Related Article: K. Mencel, P. Starynowicz, M. Siczek, A. Piecha-Bisiorek, R. Jakubas, W. Medycki|2019|Dalton Trans.|48|14829|doi:10.1039/C9DT02916H
DOI: 10.5517/ccdc.csd.cc22hvct
title: CCDC 1921856: Experimental Crystal Structure Determination

description: Related Article: Krešimir Molčanov, Valentina Milašinović, Nives Ivić, Vladimir Stilinović, Dinko Kolarić, Biserka Kojić-Prodić|2019|CrystEngComm|21|6920|doi:10.1039/C9CE00919A
DOI: 10.5517/ccdc.csd.cc22hvdv
title: CCDC 1921857: Experimental Crystal Structure Determination

description: Related Article: Krešimir Molčanov, Valentina Milašinović, Nives Ivić, Vladimir Stilinović, Dinko Kolarić, Biserka Kojić-Prodić|2019|CrystEngComm|21|6920|doi:10.1039/C9CE00919A
DOI: 10.6084/m9.figshare.13642066
title: Additional file 13 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 13. The genes involved in the GA pathway in chrysanthemum
DOI: 10.6084/m9.figshare.13642084.v1
title: Additional file 4 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 4. The DEGs annotated with the “reproduction” GO term (GO:0000003)
DOI: 10.6084/m9.figshare.13642066.v1
title: Additional file 13 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 13. The genes involved in the GA pathway in chrysanthemum
DOI: 10.6084/m9.figshare.13642069
title: Additional file 14 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 14. Important anthocyanin biosynthesis pathway functional genes in chrysanthemum
DOI: 10.6084/m9.figshare.13642078.v1
title: Additional file 2 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 2. The DEGs specifically expressed in the mutant capitula
DOI: 10.6084/m9.figshare.13642081.v1
title: Additional file 3 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 3. The DEGs specifically expressed in the normal capitula
DOI: 10.6084/m9.figshare.13642084
title: Additional file 4 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 4. The DEGs annotated with the “reproduction” GO term (GO:0000003)
DOI: 10.6084/m9.figshare.13642099.v1
title: Additional file 9 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 9. The enriched KEGG pathways among the DEGs up-regulated in the mutant capitula
DOI: 10.6084/m9.figshare.13642177
title: Additional file 7 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 7: Table S6. Additional table.
DOI: 10.6084/m9.figshare.13642087.v1
title: Additional file 5 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 5. The DEGs enriched in the biological process GO category
DOI: 10.6084/m9.figshare.13642078
title: Additional file 2 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 2. The DEGs specifically expressed in the mutant capitula
DOI: 10.6084/m9.figshare.13642087
title: Additional file 5 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 5. The DEGs enriched in the biological process GO category
DOI: 10.6084/m9.figshare.13642093
title: Additional file 7 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 7. The DEGs enriched in the cellular component GO category
DOI: 10.6084/m9.figshare.13642093.v1
title: Additional file 7 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 7. The DEGs enriched in the cellular component GO category
DOI: 10.6084/m9.figshare.13642096
title: Additional file 8 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 8. The enriched KEGG pathways among the DEGs down-regulated in the mutant capitula
DOI: 10.6084/m9.figshare.13642063.v1
title: Additional file 12 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 12. The MADS-box genes identified in chrysanthemum
DOI: 10.6084/m9.figshare.13642096.v1
title: Additional file 8 of Whole-transcriptome analysis of differentially expressed genes in the mutant and normal capitula of Chrysanthemum morifolium

description: Additional file 8. The enriched KEGG pathways among the DEGs down-regulated in the mutant capitula
DOI: 10.6084/m9.figshare.16786870
title: Additional file 1 of The genetic impact of an Ebola outbreak on a wild gorilla population

description: Additional file 1.
DOI: 10.6084/m9.figshare.13642103
title: Additional file 1 of Knowledge, attitudes, practices, and influencing factors of anxiety among pregnant women in Wuhan during the outbreak of COVID-19: a cross-sectional study

description: Additional file 1. The proof of license. It’s a PDF copy of the license from the Ethics Committee of the Wuhan Women and Children Medical Care Center.
DOI: 10.6084/m9.figshare.13642103.v1
title: Additional file 1 of Knowledge, attitudes, practices, and influencing factors of anxiety among pregnant women in Wuhan during the outbreak of COVID-19: a cross-sectional study

description: Additional file 1. The proof of license. It’s a PDF copy of the license from the Ethics Committee of the Wuhan Women and Children Medical Care Center.
DOI: 10.6084/m9.figshare.13642174.v1
title: Additional file 6 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 6: Table S5. Additional table.
DOI: 10.6084/m9.figshare.7351946
title: A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension

description: Pulmonary arterial hypertension (PAH) can be relieved by pharmacological interventions, especially the targeted drug, which is classified into endothelin receptor antagonist, phosphodiesterase 5 inhibitor, prostaglandin I<sub>2</sub>, soluble guanylate cyclase stimulator and selective non-prostanoid prostacyclin receptor agonist. To solve the contradictions existing in reported trials and provide a comprehensive guideline for clinical practice. PubMed, Embase, Cochrane library, and clinicaltrials.gov were searched. The basic information about the article, trial, arm, intervention, and the detailed data of outcome, including 6 minutes walking distance (6MWD) change, WHO functional class (FC) improvement, Borg dyspnea score (BDS) change, cardiac index (CI) change, mean pulmonary arterial pressure (mPAP) change, mean right arterial pressure (mRAP) change, pulmonary vascular resistance (PVR) change, clinical worsening, hospitalization, death, severe adverse events (SAEs), and withdrawal were extracted. The rank of treatments was estimated. 10,230 cases provided the firsthand comparison data about targeted drugs for treating PAH. For 6MWD, ambrisentan + tadalafil, vardenafil, and sildenafil + bosentan were better than others. Epoprostenol, macitentan, and sildenafil represented a greater WHO FC improvement. Vardenafil and treprostinil were better for BDS. So were bosentan + epoprostenol and bosentan alone for CI. Iloprost plus bosentan, bosentan + epoprostenol, and epoprostenol were better for mPAP. Iloprost plus bosentan, bosentan alone, and selexipag could reduce PVR. Sildenafil, epoprostenol, and vardenafil had the highest probability to reduce the incidence of death and withdrawal. To conclude, vardenafil and iloprost + bosentan showed relatively better performance in both efficacy and safety. However, the therapeutic choice should be made according to both the feature of each therapy and the individual condition.
DOI: 10.6084/m9.figshare.7351946.v2
title: A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension

description: Pulmonary arterial hypertension (PAH) can be relieved by pharmacological interventions, especially the targeted drug, which is classified into endothelin receptor antagonist, phosphodiesterase 5 inhibitor, prostaglandin I<sub>2</sub>, soluble guanylate cyclase stimulator and selective non-prostanoid prostacyclin receptor agonist. To solve the contradictions existing in reported trials and provide a comprehensive guideline for clinical practice. PubMed, Embase, Cochrane library, and clinicaltrials.gov were searched. The basic information about the article, trial, arm, intervention, and the detailed data of outcome, including 6 minutes walking distance (6MWD) change, WHO functional class (FC) improvement, Borg dyspnea score (BDS) change, cardiac index (CI) change, mean pulmonary arterial pressure (mPAP) change, mean right arterial pressure (mRAP) change, pulmonary vascular resistance (PVR) change, clinical worsening, hospitalization, death, severe adverse events (SAEs), and withdrawal were extracted. The rank of treatments was estimated. 10,230 cases provided the firsthand comparison data about targeted drugs for treating PAH. For 6MWD, ambrisentan + tadalafil, vardenafil, and sildenafil + bosentan were better than others. Epoprostenol, macitentan, and sildenafil represented a greater WHO FC improvement. Vardenafil and treprostinil were better for BDS. So were bosentan + epoprostenol and bosentan alone for CI. Iloprost plus bosentan, bosentan + epoprostenol, and epoprostenol were better for mPAP. Iloprost plus bosentan, bosentan alone, and selexipag could reduce PVR. Sildenafil, epoprostenol, and vardenafil had the highest probability to reduce the incidence of death and withdrawal. To conclude, vardenafil and iloprost + bosentan showed relatively better performance in both efficacy and safety. However, the therapeutic choice should be made according to both the feature of each therapy and the individual condition.
DOI: 10.6084/m9.figshare.13642222.v1
title: Additional file 6 of LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

description: Additional file 6: Table S3. The mRNAs banding to miR-25-3p.
DOI: 10.6084/m9.figshare.22032092
title: In vitro characterization of selected NIR FPs

description: Absorbance, steady-state fluorescence spectra and  two-photon cross-section spectra  of the selected NIR FPs measured by Mikhail Drobizhev. 
<br>
Recent progress in fluorescent protein development has generated a large diversity of near-infrared fluorescent proteins, which are rapidly becoming popular probes for a variety of imaging applications. To assist end-users with a selection of the right near-infrared fluorescent protein for a given application, we conducted a quantitative assessment of intracellular brightness, photostability, oligomeric state, and cytotoxicity of 22 near-infrared fluorescent proteins in cultured HEK cells and primary mouse neurons. The top-performing proteins were further validated for <em>in vivo</em> imaging of neurons in <em>C. elegans</em>, zebrafish, and mice as well as in liver of mice. We also assessed the applicability of the selected NIR FPs for multi-color imaging of fusions, expansion microscopy, and two-photon imaging.
DOI: 10.6084/m9.figshare.13642222
title: Additional file 6 of LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

description: Additional file 6: Table S3. The mRNAs banding to miR-25-3p.
DOI: 10.6084/m9.figshare.13642177.v1
title: Additional file 7 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 7: Table S6. Additional table.
DOI: 10.5281/zenodo.10471365
title: DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Dataset

description: Dataset for the DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Challenge

More information about the challenge can be found on the challenge website!

 

Timeline:

8th January 2024: First subset of training & validation data available.

22nd January 2024: Second subset of training & validation data available.

29th January 2024: Full training & validation data available.

 

Description:

The dataset was created using Unreal Engine 5.1, Unreal MetaHumans, 3D-COSI surgical instruments, POV-Surgery grasp generation and EasySynth.

Each scene contains:



"color": RGB input images

"gt": RGB ground truth images

"mask": Mask defining the area to be inpainted. White -> Background, Black -> Inpainting area

"CameraPoses.csv": Camera poses

"CameraRig.json": Camera intrinsics
DOI: 10.5281/zenodo.10548114
title: DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Dataset

description: Dataset for the DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Challenge

More information about the challenge can be found on the challenge website!

 

Timeline:

8th January 2024: First subset of training & validation data available (scenes 0000-0009).

22nd January 2024: Second subset of training & validation data available (scenes 0010-0049).

29th January 2024: Full training & validation data available (scenes 0050-0100).

 

Description:

The dataset was created using Unreal Engine 5.1, Unreal MetaHumans, 3D-COSI surgical instruments, POV-Surgery grasp generation and EasySynth.

Each scene contains:



"color": RGB input images

"gt": RGB ground truth images

"mask": Mask defining the area to be inpainted. White -> Background, Black -> Inpainting area

"CameraPoses.csv": Camera poses

"CameraRig.json": Camera intrinsics
DOI: 10.25387/g3.12593627
title: Supplemental Material for Yin et al., 2020

description: File S1 contains two sets of flow cytometry histograms of octoploid <i>B. napus</i> (Y3380 plants and Y3560
plants). File S2 contains two sets of flow cytometry histograms of tetraploid <i>B. napus </i>(ZS11 and P3-2). File S3 contains
two sets of flow cytometry histograms of the self-pollinated individuals
derived from octoploid <i>B. napus</i>. All these
flow cytometry fluorescence histograms were dragged out directly from the
AccuriC software. Supplemental Figures contains Figures S1-S12. Table S1
contains the fluorescence intensity values of the mitotic G1 phase of octoploid
and tetraploid <i>B. napus</i>. Table S2
contains phenotypic data of octoploid and tetraploid <i>B. napus</i>. Table S3 contains the fluorescence intensity values of the
mitotic G1 phase of self-pollinated individuals derived from octoploid <i>B. napus</i>.
DOI: 10.6084/m9.figshare.13642168
title: Additional file 4 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 4: Table S4. Additional table.
DOI: 10.6084/m9.figshare.13642168.v1
title: Additional file 4 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 4: Table S4. Additional table.
DOI: 10.6084/m9.figshare.13642174
title: Additional file 6 of Comparing the hippocampal miRNA expression profiles of wild and domesticated Chinese tree shrews (Tupaia belangeri chinensis)

description: Additional file 6: Table S5. Additional table.
DOI: 10.6084/m9.figshare.7350929
title: Additional file 1: of MicroRNAs and their targets in cucumber shoot apices in response to temperature and photoperiod

description: Table S1. summary of sRNA sequencing data. Table S2. summary of known miRNAs. Table S3. summary of novel miRNAs. Table S4. expression levels of known miRNAs in cucumber shoot tips grown in four temperature-photoperiod conditions. Table S5. expression levels of novel miRNAs in cucumber shoot tips grown in four temperature-photoperiod conditions. Table S6. targets of known miRNAs predicted by psRobot. Table S7. targets of novel miRNAs predicted by psRobot. Table S8. targets of known miRNAs predicted by TargetFinder. Table S9. targets of novel miRNAs predicted by TargetFinder. Table S10. targets of known miRNAs predicted by both psRobot and TargetFinder (intersection). Table S11. targets of novel miRNAs predicted by both psRobot and TargetFinder (intersection). Table S12. targets identified by degradome sequencing. Table S13. GO term enrichment of targets. Table S14. KEGG classification of miRNA targets. Table S15. statistics of transcriptome sequencing for each sample. Table S16. differentially expressed degradome confirmed targets. Table S17. targets (degradome proven) of the temperature and photoperiod affected miRNAs. Table S18. functional annotations (computer predicted targets) of the temperature and photoperiod affected miRNAs. (XLSX 1042Â kb)
DOI: 10.6084/m9.figshare.9973898
title: MOESM4 of IMP-ICDX: an injury mortality prediction based on ICD-10-CM codes

description: Additional file 4. WMDP values of different ICD-10-CM injury codes. (XLS 1135 kb)